Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 23,587.91%8.88M | 20,454.06%7.71M | 23,133.85%8.71M | 4,612.36%8.13M | 13,260.53%8.02M | 0.00%37.5K | 0.00%37.5K | 0.00%37.5K | -39.32%172.5K | -34.86%60K |
| Total premiums earned | --8.57M | --7.31M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Net premiums written | --8.57M | --7.31M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net investment income | --296.66K | --355.78K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Fee revenue and other income | 106.66%77.5K | 145.55%92.08K | ---- | ---- | ---- | --37.5K | --37.5K | ---- | ---- | ---- |
| -Fees and commissions | 106.66%77.5K | 145.55%92.08K | ---- | ---- | ---- | --37.5K | --37.5K | ---- | ---- | ---- |
| -Other income expense | ---- | ---- | -11.48%-302.95K | 223.35%3.33M | 383.85%2.13M | 51.23%1.03M | -41.05%442.15K | -178.00%-271.75K | 205.72%1.03M | -327.85%-750.16K |
| Interest income | ---61.05K | ---54.49K | ---- | 39.47%844.17K | 501.93%844.17K | --0 | --0 | 20.25%190.42K | 0.60%605.28K | -34.16%140.24K |
| Total expenses | 1,797.84%8.21M | 10,615.51%6.99M | 42,878.24%9.24M | 1,075.94%10.7M | 5,402.53%10.73M | -349.23%-483.6K | -119.06%-66.49K | -112.58%-21.61K | 17.95%909.57K | 21.43%195.06K |
| Loss adjustment expense | --8.29M | --6.96M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Selling general and administration | 135.06%1.14M | 243.92%1.11M | 874.39%699.09K | 292.91%1.65M | 412.80%659.16K | 574.76%486.47K | 87.65%323.48K | 52.16%71.75K | 33.08%420.17K | 139.78%128.54K |
| -General and administrative expense | 135.06%1.14M | 243.92%1.11M | 874.39%699.09K | 292.91%1.65M | 412.80%659.16K | 574.76%486.47K | 87.65%323.48K | 52.16%71.75K | 33.08%420.17K | 139.78%128.54K |
| Depreciation and amortization | --33.4K | --35.41K | --33.42K | --28.62K | --28.62K | --0 | --0 | --0 | --0 | ---- |
| -Depreciation | ---- | ---- | ---- | --28.62K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net non operatingInterest income (expenses) | 2,173.01%448.68K | 1,280.36%462.66K | -299.13%-169.36K | 261.00%301.45K | 641.49%427.7K | 41.09%-21.64K | 13.98%-39.2K | -63.60%-42.43K | -186.16%-187.24K | -331.27%-78.99K |
| -Interest expense-non operating | -92.51%17.44K | -92.30%17.44K | 129.83%535.14K | -31.52%542.72K | -168.21%-149.54K | 17.20%232.89K | 19.04%226.53K | 26.35%232.85K | 18.80%792.52K | 22.58%219.23K |
| -Interest income-non operating | ---- | 156.29%480.1K | ---- | 39.47%844.17K | 98.34%278.16K | 16.24%188.27K | 29.44%187.33K | 20.25%190.42K | 0.60%605.28K | -34.16%140.24K |
| -Total other finance cost | -120.65%-466.12K | ---- | -92.10%-365.79K | ---- | ---- | ---211.25K | ---- | ---190.42K | ---- | ---- |
| Income from associates and other participating interests | -11.40%893.31K | 76.17%778.96K | ---- | ---- | ---- | --1.01M | --442.15K | ---- | ---- | ---- |
| Special income (charges) | --0 | ---- | ---- | 1,366.24%2.6M | 1,352.07%2.57M | --0 | ---- | ---- | -121.58%-205.11K | -125.77%-205.6K |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --205.59K | ---- |
| Other Operating costs | 403.21%83.17K | 885.39%127.98K | 346.94%74.53K | 128.99%95.72K | 214.52%49.54K | -30.98%16.53K | -69.49%12.99K | -10.07%16.68K | -45.91%41.8K | -446.72%-43.25K |
| Income before tax | 28.99%672.18K | 588.86%716.33K | -292.76%-1M | 906.60%1.07M | 194.93%915.31K | 6.65%521.1K | -73.55%103.99K | -235.48%-255.08K | 149.14%105.83K | -427.01%-964.21K |
| Income tax | 69.92K | -35.67K | 3K | 127.83%26.76K | 26.76K | 0 | 0 | 0 | -96.14K | |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 15.57%602.25K | 623.16%752K | -293.94%-1M | 414.20%1.04M | 202.36%888.56K | 6.65%521.1K | -73.55%103.99K | -235.48%-255.08K | 193.77%201.97K | -394.40%-868.07K |
| Net Income continuous operations | 15.57%602.25K | 623.17%752K | -293.94%-1M | 414.20%1.04M | 202.36%888.56K | 6.65%521.1K | -73.55%103.99K | -235.48%-255.08K | 193.77%201.97K | -394.40%-868.07K |
| Noncontrolling interests | 0 | -35.67K | -35.67K | 0 | 0 | |||||
| Net income attributable to the company | 15.57%602.25K | 623.16%752K | -110.23%-998.86K | 549.71%1.31M | 233.89%1.16M | 6.65%521.1K | -73.55%103.99K | -352.36%-475.13K | 193.77%201.97K | -394.40%-868.07K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 15.57%602.25K | 623.16%752K | -110.23%-998.86K | 549.71%1.31M | 233.89%1.16M | 6.65%521.1K | -73.55%103.99K | -352.36%-475.13K | 193.77%201.97K | -394.40%-868.07K |
| Diluted earnings per share | -73.40%0.004 | 66.67%0.005 | 56.25%-0.007 | 328.57%0.03 | 132.71%0.0078 | 6.25%0.015 | -73.91%0.003 | -401.43%-0.016 | 213.05%0.007 | -370.88%-0.024 |
| Basic earnings per share | -80.05%0.003 | 33.33%0.004 | 56.25%-0.007 | 0.03 | 125.32%0.0078 | 6.25%0.015 | -73.91%0.003 | -401.43%-0.016 | 0 | -450.01%-0.031 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%0.0044 | 0 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.